Concordia Healthcare's common shares to begin trading on NASDAQ under symbol CXRX

Concordia Healthcare Corp. ("Concordia" or the "Company") (TSX: CXR) (OTCQX: CHEHF), a diverse healthcare company focused on legacy pharmaceutical products and orphan drugs, today announced that its common shares will begin trading on the NASDAQ Global Select Market® ("NASDAQ") on June 29, 2015 under the symbol CXRX.

The Company's common shares will continue to trade on the Toronto Stock Exchange.

"Our NASDAQ listing will provide increased exposure for Concordia as we continue to build our foundation as an emerging leader in the acquisition of legacy pharmaceutical products and orphan drugs," said Mark Thompson, Chief Executive Officer of Concordia.

SOURCE Concordia Healthcare Corp.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Experts assess the impact of COVID-19 on pediatric patients with special needs